{"id":"https://openalex.org/W2099533626","doi":"https://doi.org/10.1002/pds.3630","title":"Compliance after switching from branded to generic statins","display_name":"Compliance after switching from branded to generic statins","publication_year":2014,"publication_date":"2014-05-09","ids":{"openalex":"https://openalex.org/W2099533626","doi":"https://doi.org/10.1002/pds.3630","mag":"2099533626","pmid":"https://pubmed.ncbi.nlm.nih.gov/24817435"},"language":"en","primary_location":{"id":"doi:10.1002/pds.3630","doi":"https://doi.org/10.1002/pds.3630","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.3630","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024044978","display_name":"Robert J. Romanelli","orcid":"https://orcid.org/0009-0001-8244-1939","observed_orcids":["https://orcid.org/0009-0001-8244-1939"]},"institutions":[{"id":"https://openalex.org/I114073160","display_name":"Sutter Health","ror":"https://ror.org/0060avh92","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114073160"]},{"id":"https://openalex.org/I1317822957","display_name":"Palo Alto Medical Foundation","ror":"https://ror.org/04rg6e566","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I114073160","https://openalex.org/I1317822957"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert J. Romanelli","raw_affiliation_strings":["Clinical Outcomes Research Group, Clinical Integration Department; Sutter Health; Sacramento CA USA","Palo Alto Medical Foundation Research Institute, Palo Alto, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Outcomes Research Group, Clinical Integration Department; Sutter Health; Sacramento CA USA","institution_ids":["https://openalex.org/I114073160"]},{"raw_affiliation_string":"Palo Alto Medical Foundation Research Institute, Palo Alto, CA, USA","institution_ids":["https://openalex.org/I1317822957"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035459003","display_name":"Trevor Jukes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114073160","display_name":"Sutter Health","ror":"https://ror.org/0060avh92","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114073160"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Trevor Jukes","raw_affiliation_strings":["Clinical Outcomes Research Group, Clinical Integration Department; Sutter Health; Sacramento CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Outcomes Research Group, Clinical Integration Department; Sutter Health; Sacramento CA USA","institution_ids":["https://openalex.org/I114073160"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005567441","display_name":"Jodi B Segal","orcid":"https://orcid.org/0000-0003-3978-9662","observed_orcids":["https://orcid.org/0000-0003-3978-9662"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jodi B. Segal","raw_affiliation_strings":["Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5024044978"],"corresponding_institution_ids":["https://openalex.org/I114073160","https://openalex.org/I1317822957"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":1.3211,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.79125377,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"23","issue":"10","first_page":"1093","last_page":"1100"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.7910000085830688},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.8309999704360962},{"id":"https://openalex.org/keywords/brand-name-drugs","display_name":"brand-name drugs","score":0.5910000205039978},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6970000267028809},{"id":"https://openalex.org/keywords/medication-possession-ratio","display_name":"medication possession ratio","score":0.9039999842643738},{"id":"https://openalex.org/keywords/drug-substitution","display_name":"drug substitution","score":0.6200000047683716},{"id":"https://openalex.org/keywords/therapeutic-substitution","display_name":"therapeutic substitution","score":0.7580000162124634},{"id":"https://openalex.org/keywords/generic-substitution","display_name":"generic substitution","score":0.9010000228881836},{"id":"https://openalex.org/keywords/statin-dosing","display_name":"statin dosing","score":0.7960000038146973}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9130955934524536},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.7513695955276489},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6970231533050537},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.6919403076171875},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.5825743079185486},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5634401440620422},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5601476430892944},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.5462883710861206},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5192158818244934},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.5105084180831909},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.465678870677948},{"id":"https://openalex.org/C2781460075","wikidata":"https://www.wikidata.org/wiki/Q1399332","display_name":"Compliance (psychology)","level":2,"score":0.45307207107543945},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.337147057056427},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.1413169503211975},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.1394163966178894},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.0},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009657","descriptor_name":"North Carolina","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D057216","descriptor_name":"Propensity Score","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057286","descriptor_name":"Electronic Health Records","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/pds.3630","doi":"https://doi.org/10.1002/pds.3630","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.3630","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},{"id":"pmid:24817435","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24817435","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and drug safety","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"},{"id":"https://openalex.org/F4320333491","display_name":"Palo Alto Medical Foundation","ror":"https://ror.org/04rg6e566"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W2330957","https://openalex.org/W97761631","https://openalex.org/W1970799753","https://openalex.org/W1983793369","https://openalex.org/W2000445173","https://openalex.org/W2013780508","https://openalex.org/W2034718681","https://openalex.org/W2036193982","https://openalex.org/W2046981208","https://openalex.org/W2057124956","https://openalex.org/W2061326496","https://openalex.org/W2073896718","https://openalex.org/W2083718966","https://openalex.org/W2093042415","https://openalex.org/W2097319856","https://openalex.org/W2098364806","https://openalex.org/W2111635289","https://openalex.org/W2128572248","https://openalex.org/W2139062201","https://openalex.org/W2147345442","https://openalex.org/W2171860082","https://openalex.org/W2342247435","https://openalex.org/W2521452473"],"related_works":["https://openalex.org/W2118523766","https://openalex.org/W1974835952","https://openalex.org/W2147345442","https://openalex.org/W2186751705","https://openalex.org/W2109622927","https://openalex.org/W2277058807","https://openalex.org/W7096407111","https://openalex.org/W2077083000","https://openalex.org/W1991134771","https://openalex.org/W1999888718"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1],"purpose":[2],"of":[3,11,85,88,145,159],"this":[4,23],"study":[5],"was":[6,80,233],"to":[7,15,142,156,173,213,240,256],"evaluate":[8],"the":[9,72,83,117,146,191],"impact":[10],"switching":[12,196,221],"from":[13,39,139,153],"branded":[14,31,59,141,155,247],"generic":[16,55,143,157,176,214,241],"statins":[17,32,56,60,242],"on":[18,71,246],"medication":[19],"compliance.":[20],"METHODS:":[21],"In":[22],"historic":[24],"cohort":[25],"study,":[26],"we":[27],"identified":[28],"patients":[29,109,137,208,237],"taking":[30],"between":[33],"January":[34],"2003":[35],"and":[36,66,182,243],"December":[37],"2012":[38],"Sutter":[40],"Health's":[41],"electronic":[42],"health":[43],"records":[44],"in":[45,98,116,123,190],"Northern":[46],"California.":[47],"Patients":[48,151],"with":[49,125,175,187,209,230],"\u22652":[50],"consecutive":[51],"pharmacy":[52],"claims":[53],"for":[54,74,130],"after":[57,195,220],"initiating":[58],"were":[61,68,114,128,183],"classified":[62],"as":[63,82],"switchers.":[64],"Switchers":[65],"non-switchers":[67,131],"matched":[69,118],"1:1":[70],"propensity":[73],"switching.":[75],"Medication":[76],"possession":[77],"ratio":[78],"(MPR)":[79],"calculated":[81],"sum":[84],"days":[86],"supply":[87],"therapy":[89,127,189,232,255],"divided":[90],"by":[91,103],"treatment":[92],"duration.":[93],"We":[94],"assessed":[95],"between-group":[96],"differences":[97,122],"compliance":[99,124,204],"(MPR":[100],"\u2265":[101],"0.80)":[102],"logistic":[104],"regression.":[105],"RESULTS:":[106],"Among":[107],"16,364":[108],"meeting":[110],"eligibility":[111],"criteria,":[112],"8470":[113],"retained":[115],"cohort.":[119],"No":[120],"significant":[121],"statin":[126,144,158,170,188,231],"observed":[129],"versus":[132,136],"switchers,":[133],"overall,":[134],"or":[135],"switched":[138,152],"a":[140,154,160],"same":[147],"agent":[148,162],"(generic":[149],"substitutions).":[150],"different":[161],"(therapeutic":[163],"substitutions)":[164],"more":[165,216],"frequently":[166],"received":[167],"less":[168,185],"potent":[169],"dosing":[171],"relative":[172,212],"those":[174,244],"substitutions":[177,211,215],"(42.2%":[178],"vs.":[179,198,223],"<2%,":[180],"respectively)":[181],"significantly":[184,205],"compliant":[186],"first":[192],"6":[193],"months":[194,219],"(73.9%":[197],"77.6%;":[199],"p":[200,225],"=":[201,226],"0.011);":[202],"however,":[203],"improved":[206],"among":[207,236],"therapeutic":[210],"than":[217],"12":[218],"(66.2%":[222],"61.3%;":[224],"0.021).":[227],"CONCLUSIONS:":[228],"Compliance":[229],"largely":[234],"similar":[235],"who":[238],"switch":[239],"remaining":[245],"statins.":[248],"Dosing":[249],"should":[250],"be":[251],"reviewed":[252],"when":[253],"changing":[254],"optimize":[257],"clinical":[258],"outcomes.":[259]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}